Literature DB >> 17238830

Soluble human MDA-7/IL-24: characterization of the molecular form(s) inhibiting tumor growth and stimulating monocytes.

John B Mumm1, Suhendan Ekmekcioglu, Nancy J Poindexter, Sunil Chada, Elizabeth A Grimm.   

Abstract

Interleukin-24 (IL-24), also known as melanoma differentiation-associated gene-7 (mda-7), is a member of the IL-10 family that exhibits both tumor suppressor and proinflammatory properties. We describe the purification of this novel dual-function tumor suppressor/cytokine from the supernatant of IL-24 gene-transfected HEK 293 cells and define the biochemical and functional properties of the soluble human IL-24 protein. Size exclusion chromatography demonstrates that an IL-24 macromolecular complex fractionates in a broad peak with a median of 110 kDa and comprises several IL-24 isoforms, identified by immunoblotting with anti-IL-24 polyclonal antibody after reducing SDS-PAGE analysis. IL-24 was found to associate with two serum components, albumin and C1q. Cation exchange purification results in the isolation of at least two N-linked glycosylated IL-24 dimers covalently associated via intermolecular disulfide bonds. These molecularly defined N-glycosylated IL-24 dimers elicited dose-dependent secretion of tumor necrosis factor-alpha (TNF-alpha) and IL-6 from human monocytes, as well as cytotoxicity to human melanoma cell lines. Thus, we demonstrated that the secreted, glycosylated, dimeric, human IL-24 is immunomodulatory to monocytes and exhibits tumor cell growth inhibition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17238830     DOI: 10.1089/jir.2006.26.877

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  7 in total

1.  IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytes.

Authors:  Nancy J Poindexter; Ryan R Williams; Garth Powis; Emily Jen; Abigail S Caudle; Sunil Chada; Elizabeth A Grimm
Journal:  Exp Dermatol       Date:  2010-08       Impact factor: 3.960

2.  Structural mapping of post-translational modifications in human interleukin-24: role of N-linked glycosylation and disulfide bonds in secretion and activity.

Authors:  Kerry L Fuson; Mingzhong Zheng; Molly Craxton; Abujiang Pataer; Rajagopal Ramesh; Sunil Chada; R Bryan Sutton
Journal:  J Biol Chem       Date:  2009-09-04       Impact factor: 5.157

Review 3.  Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases.

Authors:  Mitchell E Menezes; Praveen Bhoopathi; Anjan K Pradhan; Luni Emdad; Swadesh K Das; Chunqing Guo; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

4.  Killing of human melanoma cells induced by activation of class I interferon-regulated signaling pathways via MDA-7/IL-24.

Authors:  Suhendan Ekmekcioglu; John B Mumm; Malini Udtha; Sunil Chada; Elizabeth A Grimm
Journal:  Cytokine       Date:  2008-06-03       Impact factor: 3.861

5.  IL-24 modulates IFN-gamma expression in patients with tuberculosis.

Authors:  Bo Wu; Chunhong Huang; Midori Kato-Maeda; Philip C Hopewell; Charles L Daley; Alan M Krensky; Carol Clayberger
Journal:  Immunol Lett       Date:  2007-12-26       Impact factor: 3.685

6.  MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.

Authors:  Mitchell E Menezes; Xue-Ning Shen; Swadesh K Das; Luni Emdad; Chunqing Guo; Fang Yuan; You-Jun Li; Michael C Archer; Eldad Zacksenhaus; Jolene J Windle; Mark A Subler; Yaacov Ben-David; Devanand Sarkar; Xiang-Yang Wang; Paul B Fisher
Journal:  Oncotarget       Date:  2015-11-10

Review 7.  Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.

Authors:  Luni Emdad; Praveen Bhoopathi; Sarmistha Talukdar; Anjan K Pradhan; Devanand Sarkar; Xiang-Yang Wang; Swadesh K Das; Paul B Fisher
Journal:  Semin Cancer Biol       Date:  2019-07-26       Impact factor: 15.707

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.